{"id":"https://openalex.org/W7225032991","doi":"https://doi.org/10.1021/acs.jmedchem.6c02907","title":"Lipid-Modified CGRP Receptor Antagonists: Balancing Pharmacokinetic Improvement and Potency Loss","display_name":"Lipid-Modified CGRP Receptor Antagonists: Balancing Pharmacokinetic Improvement and Potency Loss","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225032991","doi":"https://doi.org/10.1021/acs.jmedchem.6c02907"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.6c02907","doi":"https://doi.org/10.1021/acs.jmedchem.6c02907","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.6c02907","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160266133","display_name":"AL Schofield","orcid":"https://orcid.org/0000-0001-5399-7279","observed_orcids":["https://orcid.org/0000-0001-5399-7279"]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Adam L. Schofield","raw_affiliation_strings":["The University of Edinburgh , , Joseph Black Building, David Brewster Road , ,"],"raw_orcid":"https://orcid.org/0000-0001-5399-7279","affiliations":[{"raw_affiliation_string":"The University of Edinburgh , , Joseph Black Building, David Brewster Road , ,","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160258947","display_name":"M Ro\u017e\u0148ovcov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I71052956","display_name":"University of Reading","ror":"https://ror.org/05v62cm79","country_code":"GB","type":"education","lineage":["https://openalex.org/I71052956"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ma\u0301ria Roz\u030cn\u030covcova\u0301","raw_affiliation_strings":["University of Reading , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Reading , , ,","institution_ids":["https://openalex.org/I71052956"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160277639","display_name":"V D\u2019Aloisio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I63098007","display_name":"Liverpool John Moores University","ror":"https://ror.org/04zfme737","country_code":"GB","type":"education","lineage":["https://openalex.org/I63098007"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Vera D\u2019Aloisio","raw_affiliation_strings":["Liverpool John Moores University , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Liverpool John Moores University , , ,","institution_ids":["https://openalex.org/I63098007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160246021","display_name":"RKY Tan","orcid":"https://orcid.org/0009-0003-4836-4583","observed_orcids":["https://orcid.org/0009-0003-4836-4583"]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ryan K. Y. Tan","raw_affiliation_strings":["The University of Edinburgh , , Joseph Black Building, David Brewster Road , ,"],"raw_orcid":"https://orcid.org/0009-0003-4836-4583","affiliations":[{"raw_affiliation_string":"The University of Edinburgh , , Joseph Black Building, David Brewster Road , ,","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160242466","display_name":"G Hutcheon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I63098007","display_name":"Liverpool John Moores University","ror":"https://ror.org/04zfme737","country_code":"GB","type":"education","lineage":["https://openalex.org/I63098007"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gillian A. Hutcheon","raw_affiliation_strings":["Liverpool John Moores University , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Liverpool John Moores University , , ,","institution_ids":["https://openalex.org/I63098007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160260614","display_name":"GS Cottrell","orcid":"https://orcid.org/0000-0001-9098-7627","observed_orcids":["https://orcid.org/0000-0001-9098-7627"]},"institutions":[{"id":"https://openalex.org/I71052956","display_name":"University of Reading","ror":"https://ror.org/05v62cm79","country_code":"GB","type":"education","lineage":["https://openalex.org/I71052956"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Graeme S. Cottrell","raw_affiliation_strings":["University of Reading , , ,"],"raw_orcid":"https://orcid.org/0000-0001-9098-7627","affiliations":[{"raw_affiliation_string":"University of Reading , , ,","institution_ids":["https://openalex.org/I71052956"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5160280963","display_name":"CR Coxon","orcid":"https://orcid.org/0000-0002-3375-3901","observed_orcids":["https://orcid.org/0000-0002-3375-3901"]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Christopher R. Coxon","raw_affiliation_strings":["The University of Edinburgh , , Joseph Black Building, David Brewster Road , ,"],"raw_orcid":"https://orcid.org/0000-0002-3375-3901","affiliations":[{"raw_affiliation_string":"The University of Edinburgh , , Joseph Black Building, David Brewster Road , ,","institution_ids":["https://openalex.org/I98677209"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5160260614","https://openalex.org/A5160280963"],"corresponding_institution_ids":["https://openalex.org/I71052956","https://openalex.org/I98677209"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.8842999935150146,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.8842999935150146,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.033900000154972076,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.02449999935925007,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/calcitonin-gene-related-peptide-receptor-antagonist","display_name":"calcitonin gene-related peptide receptor antagonist","score":0.8460000157356262},{"id":"https://openalex.org/keywords/lipidation","display_name":"lipid modification","score":0.6589999794960022},{"id":"https://openalex.org/keywords/peptide-stability","display_name":"peptide stability","score":0.5619999766349792},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.828000009059906},{"id":"https://openalex.org/keywords/peg-spacer","display_name":"PEG spacer","score":0.906000018119812},{"id":"https://openalex.org/keywords/n-terminal-modification","display_name":"N-terminal modification","score":0.7350000143051147},{"id":"https://openalex.org/keywords/migraine-treatment","display_name":"migraine treatment","score":0.7120000123977661},{"id":"https://openalex.org/keywords/serum-albumin-binding","display_name":"serum albumin binding","score":0.6420000195503235}],"concepts":[{"id":"https://openalex.org/C193469717","wikidata":"https://www.wikidata.org/wiki/Q6556349","display_name":"Lipid-anchored protein","level":4,"score":0.7646999955177307},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.7572000026702881},{"id":"https://openalex.org/C163170386","wikidata":"https://www.wikidata.org/wiki/Q419432","display_name":"Calcitonin gene-related peptide","level":4,"score":0.7494999766349792},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6330999732017517},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5738000273704529},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.542900025844574},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5221999883651733},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4674000144004822},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4041000008583069},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.3440000116825104},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.3391000032424927},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.32109999656677246},{"id":"https://openalex.org/C2779627488","wikidata":"https://www.wikidata.org/wiki/Q315860","display_name":"Calcitonin","level":2,"score":0.3174000084400177},{"id":"https://openalex.org/C43554185","wikidata":"https://www.wikidata.org/wiki/Q425649","display_name":"LDL receptor","level":4,"score":0.3167000114917755},{"id":"https://openalex.org/C4733338","wikidata":"https://www.wikidata.org/wiki/Q2792936","display_name":"Lipid metabolism","level":2,"score":0.311599999666214},{"id":"https://openalex.org/C2991874392","wikidata":"https://www.wikidata.org/wiki/Q1124842","display_name":"Metabolic stability","level":3,"score":0.2847999930381775},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.27970001101493835},{"id":"https://openalex.org/C167625842","wikidata":"https://www.wikidata.org/wiki/Q899763","display_name":"Peptide sequence","level":3,"score":0.27230000495910645},{"id":"https://openalex.org/C13935069","wikidata":"https://www.wikidata.org/wiki/Q2157266","display_name":"Oligopeptide","level":3,"score":0.2526000142097473}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.jmedchem.6c02907","doi":"https://doi.org/10.1021/acs.jmedchem.6c02907","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.6c02907","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmh:oai:researchonline.ljmu.ac.uk:29756","doi":null,"is_oa":false,"landing_page_url":"https://orcid.org/0000-0002-9786-2074","pdf_url":null,"source":{"id":"https://openalex.org/S4306401246","display_name":"Liverpool John Moores University","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I63098007","host_organization_name":"Liverpool John Moores University","host_organization_lineage":["https://openalex.org/I63098007"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320326","display_name":"University of Reading","ror":"https://ror.org/05v62cm79"},{"id":"https://openalex.org/F4320322390","display_name":"Liverpool John Moores University","ror":"https://ror.org/04zfme737"},{"id":"https://openalex.org/F4320330889","display_name":"Neurosciences Foundation","ror":"https://ror.org/01fy9e204"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W1988916919","https://openalex.org/W1997811421","https://openalex.org/W2024580043","https://openalex.org/W2037555314","https://openalex.org/W2051963341","https://openalex.org/W2063557162","https://openalex.org/W2072927591","https://openalex.org/W2079123198","https://openalex.org/W2111112233","https://openalex.org/W2125550441","https://openalex.org/W2126704964","https://openalex.org/W2152848856","https://openalex.org/W2160471073","https://openalex.org/W2162155596","https://openalex.org/W2263138261","https://openalex.org/W2405518602","https://openalex.org/W2559228210","https://openalex.org/W2765091532","https://openalex.org/W2791577408","https://openalex.org/W2889727161","https://openalex.org/W2906119091","https://openalex.org/W2907814269","https://openalex.org/W2951847940","https://openalex.org/W3025708624","https://openalex.org/W3038032073","https://openalex.org/W3045729180","https://openalex.org/W3048271700","https://openalex.org/W3132180522","https://openalex.org/W3172509480","https://openalex.org/W3209664507","https://openalex.org/W4212959738","https://openalex.org/W4214764520","https://openalex.org/W4220897749","https://openalex.org/W4220994409","https://openalex.org/W4281388633","https://openalex.org/W4319971623","https://openalex.org/W4324148913","https://openalex.org/W4383313642","https://openalex.org/W4385841639","https://openalex.org/W4386047106","https://openalex.org/W4386993732","https://openalex.org/W4387780386","https://openalex.org/W4406314061","https://openalex.org/W4407106537","https://openalex.org/W4408688943","https://openalex.org/W4414051228","https://openalex.org/W4415478914","https://openalex.org/W4416457607","https://openalex.org/W7134071220","https://openalex.org/W7204917213"],"related_works":["https://openalex.org/W3084169720","https://openalex.org/W4220994409","https://openalex.org/W1914378665","https://openalex.org/W4402942157","https://openalex.org/W4389043282","https://openalex.org/W7134071220","https://openalex.org/W2588956390","https://openalex.org/W2057927105","https://openalex.org/W1965416288","https://openalex.org/W2017572018"],"abstract_inverted_index":{"Abstract":[0],"Lipidation":[1],"is":[2],"a":[3,41,50,57,77,84,120],"promising":[4],"strategy":[5],"for":[6,52,126],"enhancing":[7],"peptide":[8,37,45,109,128,149],"stability":[9,75],"by":[10,83],"reducing":[11],"proteolytic":[12],"degradation":[13],"and":[14,31,95,111,123,148],"prolonging":[15],"systemic":[16],"exposure.":[17],"In":[18,116],"this":[19],"study,":[20],"we":[21,118],"systematically":[22],"evaluated":[23],"lipid":[24,28,60],"motifs":[25],"varying":[26],"in":[27,64,76,86,107],"chain":[29],"length":[30],"PEG":[32],"spacer":[33],"composition,":[34],"combined":[35],"with":[36],"N-terminal":[38],"modifications,":[39],"using":[40],"10-mer":[42],"calcitonin":[43],"gene-related":[44],"receptor":[46,87],"antagonist":[47],"to":[48,68,130],"optimize":[49],"candidate":[51],"migraine":[53],"treatment.":[54],"Incorporation":[55],"of":[56,103,136],"C18":[58],"diacid":[59],"motif":[61],"increased":[62],"the":[63,90,104],"vivo":[65],"(mouse)":[66],"half-life":[67],"3.5":[69],"h.":[70],"Although":[71],"lipidation":[72],"improved":[73],"serum":[74,132],"size-dependent":[78],"manner,":[79],"it":[80],"was":[81],"accompanied":[82],"reduction":[85],"antagonism,":[88],"highlighting":[89],"balance":[91],"between":[92],"pharmacokinetic":[93],"enhancement":[94],"biological":[96],"activity.":[97],"These":[98],"findings":[99],"improve":[100],"our":[101],"understanding":[102],"trade-offs":[105],"involved":[106],"lipidated":[108],"design":[110],"support":[112],"future":[113],"optimization":[114],"strategies.":[115],"addition,":[117],"developed":[119],"rapid,":[121],"inexpensive,":[122],"HPLC-compatible":[124],"assay":[125],"quantifying":[127],"binding":[129],"human":[131],"albumin,":[133],"overcoming":[134],"limitations":[135],"conventional":[137],"equilibrium":[138],"dialysis":[139],"methods,":[140],"including":[141],"non-specific":[142],"membrane":[143],"binding,":[144],"lengthy":[145],"equilibration":[146],"times,":[147],"degradation.":[150]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-01T00:00:00"}